US Oncology
Research Centers Launch Genomic Cancer Care Alliance to Personalize Care via Whole-Genome Sequencing
Premium
The Genomic Cancer Care Alliance — which currently involves founding organizations Fox Chase Cancer Center, Scripps Genomic Medicine, Omicia, El Camino Hospital, and the Translational Genomics Research Institute — plans to launch a pilot study to investigate the ability of whole-genome sequencing to guide treatment for patients who have responded poorly to initial therapy.
Life Technologies Launches Alliance to Evaluate Whole-Genome Sequencing for Guiding Cancer Treatment
Premium
The alliance is primarily funded by Life Technologies for now and will use the company's SOLiD 4 sequencing platform. Other founding partners include the Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute.
Life Technologies, Research Partners Launch Cancer Care Alliance
The firm has teamed with Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute to help people with cancer gain access to better treatment options through analysis of their genomic information.
Life Tech, TGen, US Oncology to Partner on Breast Cancer Sequencing Study Aimed at Therapy Advice
Premium
The goal of the study is "to demonstrate whether genomic sequencing of cancer tissues can provide clues for treatment strategies for these individuals," according to the partners.